Overview
OABI market data
Price History
OABI price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.57 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.57 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -187.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.30 – $3.55 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $492.9M · P/B 1.00 · P/S 17.03.
Company News
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On FridayBenzinga · Aug 7, 2026, 7:35 PM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Aug 7, 2026, 5:05 PM
OmniAb shares are trading higher after the company reported better-than-expected Q2 financial results. The company also raised its FY2026 sales guidance above estimates.Benzinga · Aug 7, 2026, 3:33 PM
OmniAb Raises FY2026 Sales Guidance from $28.000M-$33.000M to $32.000M-$36.000M vs $30.807M EstBenzinga · Aug 6, 2026, 8:24 PM
OmniAb Q2 EPS $(0.05) Beats $(0.12) Estimate, Sales $13.415M Beat $4.693M EstimateBenzinga · Aug 6, 2026, 8:09 PM
VERAXA Biotech Advances Bispecific ADC VXA‑222 With OmniAb Milestone, Moving Alliance Into Next Phase Of Cancer Therapy DiscoveryBenzinga · Jul 27, 2026, 11:07 AM
8-K filing — OmniAb, Inc. (OABI)SEC EDGAR · Jul 13, 2026, 12:06 PM
OmniAb Names Amechi Nwachuku To Newly-Created Position Of Executive Vice President And COOBenzinga · Jul 13, 2026, 12:05 PM
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development TimelinesGlobenewswire Inc · Jul 6, 2026, 11:15 AM